{
    "source_document": "output_results/resized_images/soa_1_page_1_fitz_resized.png",
    "source_page_number": 0,
    "processing_timestamp_utc": "2025-11-25T21:37:07.390446+00:00",
    "status": "Layout extraction successful (Docker Inference)",
    "content": [
        {
            "extraction_id": 0,
            "metadata": {
                "source_page": 0,
                "type": "Page-header",
                "bbox": {
                    "xmin": 0.1123,
                    "ymin": 0.2578,
                    "xmax": 0.8857,
                    "ymax": 0.2805
                }
            },
            "confidence": "N/A",
            "extraction_status": "Success",
            "data": {
                "type": "textual",
                "content": "**_Symphogen Trial ID: Sym004-09_** # Clinical Trial Protocol Version 4.0"
            }
        },
        {
            "extraction_id": 1,
            "metadata": {
                "source_page": 0,
                "type": "Text",
                "bbox": {
                    "xmin": 0.1113,
                    "ymin": 0.6672,
                    "xmax": 0.8789,
                    "ymax": 0.6977
                }
            },
            "confidence": "N/A",
            "extraction_status": "Success",
            "data": {
                "type": "textual",
                "content": "Abbreviations (in alphabetical order): ADA, anti-drug antibody; C, Cycle; CT, computed tomography scan; D/d, day(s); DLT, dose-limiting toxicity; EOT, End of trial treatment Visit (Sym004 and FOLFIRI); ECG, electrocardiography; ECOG PS, Eastern Cooperative Oncology Group performance status; MRI, magnetic resonance imaging; 1M FUP, One Month Follow-up Visit; PK, pharmacokinetic; (S)AE, (serious) adverse event; TX, therapy"
            }
        },
        {
            "extraction_id": 2,
            "metadata": {
                "source_page": 0,
                "type": "Footnote",
                "bbox": {
                    "xmin": 0.1133,
                    "ymin": 0.7055,
                    "xmax": 0.248,
                    "ymax": 0.7141
                }
            },
            "confidence": "N/A",
            "extraction_status": "Success",
            "data": {
                "type": "textual",
                "content": "\\*Omitted with Amendment 3"
            }
        },
        {
            "extraction_id": 3,
            "metadata": {
                "source_page": 0,
                "type": "Page-footer",
                "bbox": {
                    "xmin": 0.1123,
                    "ymin": 0.7328,
                    "xmax": 0.8838,
                    "ymax": 0.743
                }
            },
            "confidence": "N/A",
            "extraction_status": "Success",
            "data": {
                "type": "textual",
                "content": "Confidential Page 35 of 122"
            }
        },
        {
            "extraction_id": 4,
            "metadata": {
                "source_page": 0,
                "type": "Table",
                "bbox": {
                    "xmin": 0.1143,
                    "ymin": 0.3063,
                    "xmax": 0.8867,
                    "ymax": 0.6609
                }
            },
            "confidence": "N/A",
            "extraction_status": "Success",
            "data": {
                "type": "tabular",
                "content_html": "<table>\n  <tr>\n    <td colspan=\"2\">Pre-Treatment Phase</td>\n    <td colspan=\"7\">Treatment Phase1</td>\n    <td colspan=\"2\">Post-Treatment Phase</td>\n  </tr>\n  <tr>\n    <td>Cycle Number</td>\n    <td>Screening</td>\n    <td colspan=\"3\">Cycle 1</td>\n    <td colspan=\"2\">Cycle 2, 4, 6 etc.</td>\n    <td colspan=\"2\">Cycle 3, 5, 7 etc.</td>\n    <td>EOT</td>\n    <td>1M FUP</td>\n  </tr>\n  <tr>\n    <td>Day within Cycle\nVisit Window (\u00b1 days)</td>\n    <td>D-14 to D-1</td>\n    <td>D1</td>\n    <td>D8\n(\u00b12)</td>\n    <td>D15\n(\u00b12)</td>\n    <td>D22\n(\u00b12)</td>\n    <td>D1</td>\n    <td>D15\n(\u00b12)</td>\n    <td>D1</td>\n    <td>D15\n(\u00b12)</td>\n    <td>\u2264 10 d from the decision of trial treatment withdrawal</td>\n    <td>1 month after last dose of trial treatment (28+7d)</td>\n  </tr>\n  <tr>\n    <td>Informed Consent</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Baseline Characteristics/Eligibility2</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Safety Assessments</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Medication Survey</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>(S)AE Survey and Reporting</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>DLT Evaluation (dose-escalation only)3</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>C2/D1</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Vital Signs and Body Weight</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>ECOG PS</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>Physical Examination</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>Dermatological Examination</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>ECG4</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Safety blood samples5</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>Urinalysis5</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>Pregnancy Test</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Disease Assessments</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>(Archival) Tumor Biopsy Collection6,7</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Tumor Marker Evaluation8</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>End of C</td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>Disease Status Evaluation by CT/ MR9,10</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>End of C</td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>Additional Assessments</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>*PK Samples (dose-escalation only)11</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>*ADA Sample</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>*Biomarker Blood and Urine Sample12</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td>End of C2</td>\n    <td></td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Trial Treatment</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Skin Toxicity Prophylaxis and TX13</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n  </tr>\n  <tr>\n    <td>Infusion Reaction Prophylaxis 14</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Sym004 Infusion</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Gastrointestinal Toxicity Prophylaxis 15</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>FOLFIRI Infusion</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n  </tr>\n  <tr>\n    <td>Post-Infusion Monitoring</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td></td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td>X</td>\n    <td></td>\n    <td></td>\n  </tr>\n</table>"
            }
        },
        {
            "extraction_id": 5,
            "metadata": {
                "source_page": 0,
                "type": "Caption",
                "bbox": {
                    "xmin": 0.3506,
                    "ymin": 0.2938,
                    "xmax": 0.6465,
                    "ymax": 0.3039
                }
            },
            "confidence": "N/A",
            "extraction_status": "Success",
            "data": {
                "type": "textual",
                "content": "** 2 Flow Chart \u2013 Schedule of Assessments**"
            }
        }
    ]
}